MAPT and Alzheimer disease: Genomics, the study of describing and quantifying all genes and mutations in an organism, can identify new loci that increase AD risk and is critical to understanding the underlying causes of AD,176 such as high‐risk mutated genes of APP, PS1, Tau, APOE4, and so on.